1. Home
  2. Analysis
  3. Varubi
  4. Dyspnea
Please log in to access this page.

Varubi and Dyspnea - a phase IV clinical study of FDA data

Summary:

Dyspnea is reported as a side effect among people who take Varubi (rolapitant hydrochloride), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Xpovio, and have Nausea.

The phase IV clinical study analyzes which people have Dyspnea when taking Varubi. It is created by eHealthMe based on reports of 572 people who have side effects when taking Varubi from the FDA, and is updated regularly.

What is Varubi?

Varubi has active ingredients of rolapitant hydrochloride. eHealthMe is studying from 572 Varubi users. Check the latest studies of Varubi.

What is Dyspnea?

Dyspnea (difficult or laboured breathing) is found to be associated with 3,716 drugs and 6,067 conditions by eHealthMe. Check the latest studies of Dyspnea.

On Jul, 15, 2026

572 people reported to have side effects when taking Varubi.
Among them, 26 people (4.55%) have Dyspnea.

Could Varubi cause Dyspnea?

Among these 26 people:

How long have people been on Varubi when they have Dyspnea? *

  • < 1 month: 100 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

What is the gender of people who have Dyspnea when taking Varubi? *

  • female: 75 %
  • male: 25 %

What is the age of people who have Dyspnea when taking Varubi? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 4.55 %
  • 30-39: 4.55 %
  • 40-49: 9.09 %
  • 50-59: 27.27 %
  • 60+: 54.55 %

What are other drugs people take besides Varubi? *

  1. Aloxi: 2 people, 7.69%
  2. Xpovio: 2 people, 7.69%
  3. Lasix: 1 person, 3.85%
  4. Amlodipine: 1 person, 3.85%
  5. Carafate: 1 person, 3.85%
  6. Cymbalta: 1 person, 3.85%
  7. Decadron: 1 person, 3.85%
  8. Gemcitabine: 1 person, 3.85%
  9. Glucophage: 1 person, 3.85%
  10. Humalog: 1 person, 3.85%

What are other side effects people have besides Dyspnea? *

  1. Infusion Related Reaction: 10 people, 38.46%
  2. Oxygen Saturation Decreased: 7 people, 26.92%
  3. Chest Pain: 7 people, 26.92%
  4. Skin Blushing/flushing (a sudden reddening of the face, neck): 7 people, 26.92%
  5. Back Pain: 6 people, 23.08%
  6. Dizziness: 5 people, 19.23%
  7. Nausea (feeling of having an urge to vomit): 5 people, 19.23%
  8. Fatigue (feeling of tiredness): 3 people, 11.54%
  9. Blood Potassium Decreased: 2 people, 7.69%
  10. Hypotension (abnormally low blood pressure): 2 people, 7.69%

What are the existing conditions these people have? *

  1. Nausea (feeling of having an urge to vomit): 6 people, 23.08%
  2. Nausea And Vomiting: 5 people, 19.23%
  3. Multiple Myeloma (cancer of the plasma cells): 2 people, 7.69%
  4. Pain: 1 person, 3.85%
  5. Ovarian Cancer (cancer of ovary): 1 person, 3.85%
  6. Insomnia (sleeplessness): 1 person, 3.85%
  7. Functional Gastrointestinal Disorder (functional problem in separate organs of gastrointestinal system): 1 person, 3.85%

* Approximation only. Some reports may have incomplete information.

Do you take Varubi and have Dyspnea?

- Check whether Dyspnea is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Varubi:

Dyspnea treatments and more:

How severe was Dyspnea and when was it recovered:

Expand to all the drugs that have ingredients of rolapitant hydrochloride:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Varubi:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Dyspnea:

Browse all the conditions that are associated with Dyspnea:

How the study uses the data?

The study uses data from the FDA. It is based on rolapitant hydrochloride (the active ingredients of Varubi) and Varubi (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.